Fibrotic Lung Disease: Wharton's Jelly Stem Cells

We are studying the safety and effects of a stem cell treatment for people with fibrotic interstitial lung diseases. This research aims to see if it can improve lung function and quality of life.

1-2 years 6-10 visits Safety phase (I)Efficacy phase (II)Investigational Medicines Oral InjectionInternal MedicinePulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Esbriet

Esbriet is a medicine that helps slow lung scarring and breathing decline in people with idiopathic pulmonary fibrosis.

Nintedanib

Nintedanib is a medicine used to slow lung scarring (pulmonary fibrosis) and help people keep breathing better.

Ofev

Ofev is a medicine used to slow down scarring of the lungs in certain progressive lung diseases.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Nintedanib

Nintedanib is a substance that helps slow lung scarring in fibrotic lung diseases and is also used to treat some cancers.

Nintedanib Esylate

Nintedanib esylate is a substance that helps slow lung scarring in progressive fibrotic lung diseases and treats certain cancers.

Pirfenidone

Pirfenidone is a substance that helps slow lung scarring and preserve breathing in people with pulmonary fibrosis.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Dimethylsulfoxide

Mesenchymal Stem Cells

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Agarf

Blamonehel

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Uniwersyteckie Centrum Kliniczne

Klinika Alergologii i Pneumonologii

Suchanino, Poland

Sponsor: Medical University Of Gdansk

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.